Follow us

1-877-WHY-LEAK

1-877-949-5325 9195 Sunset Drive Suite 110
Miami, Florida. 33173

A Quick Guide to HIFU Prostate Cancer Treatment Procedure

Doctor

If you’ve been diagnosed with prostate cancer and are in the process of exploring your treatment options, you probably have a lot of questions. There are several treatment options available, but science is far from settling which is the optimal treatment. The fact is that there is no such thing as one treatment fits all. Prostate cancer therapy should be based on the particular parameters of the patient, such as age, Gleason score, PSA and concerning for preserving sexual and urinary function. This quick guide will attempt to answer some of your questions about a relatively new treatment called the HIFU procedure. HIFU stands for high-intensity focused ultrasound.

After extensive years of research and development, under the leadership of Dr. George Suarez, founder of Sona care and medical director of the FDA trials, on October 2015, the FDA granted approval of HIFU for the treatment of prostate cancer.

Who Are the Best Candidates for This Treatment?

The ideal candidates are patients with first time diagnosed with localize prostate cancer. However, it can also be used for reoccurrence cases after failed radiation as well as patient on hormone therapy, but the cancer remains confined to the prostate.

After the HIFU Procedure

This is an outpatient procedure. The follow up evaluation is based on the results of a blood test called prostate specific antigen or PSA that is performed at 4 months after the treatment. The goal of HIFU is to offer a cure, but additional benefits are reduced side effects common with surgery and/or radiation, such as impotence and urinary incontinence. In addition, there is no pain associated with the treatment and most men return to their normal life within 24 hours.

However, there are some reported side effects. Remember, not all patients experience any or all of the side effects, which include erectile dysfunction and/or impotence in 30-70 percent of patients, ejaculation problems, incontinence, rectal wall injury, prostate infection, and risk of recurrence between treatments.

For additional information, visit the following websites:

www.hifumedicalexpert.com,
www.suarezurology.com
hifucencerprostata.com